Linus Pauling Biotech Symposium

Nobel-Pauling Biotech Symposium Agenda

12th Nobel Pauling Biotech Symposium: CEO Pow-Wow - May 4-5, 2007, MIT Faculty Club
Agenda & Photos

Day 1 Friday May 4, 2007 (Agenda)

May 4, 2007	Mixing good business with exciting science and finding synergy globally
2:00 pm	Registration (Coffee & Tea: 2pm to 9pm )
3:00 pm	Welcome and opening remarks Dr. Grace Wong, CSO, ActoKine Therapeutics (5 min) Smart pitch by CEO or the international chiefs Ron Vincent, CEO, Bioconscientific, Moderator "what is a Pow-Wow" Michael Goldberg, MIT (Dr Pauling was a true genius, 5 min)
4:00 pm to 6:00pm	Keynote presentation Dr. Andrew Denker MD, PhD. Sr. Director, Clinical Pharmacology, Merck Seminar Title: Phase I Studies: a Worldwide Approach (45 min) Dr. Jeremy Levin, DPhil , MB BChir. Global Head, Novartis Dr. James N Little PhD, Former Waters, Zymark and Cetek (Chair) Dr. Jeffrey Moore, PhD, MBA, Kauffman Fellow, RCT BioVentures (chair)
5:30 pm	Networking (smart pitch) Speaker Group photo (5 min) for Dr Linus Pauling Jr.
6:00 pm	Dr. Xian Lu Qu, Xianlu, Merck (Chair) Dr. Glenn Rice, PhD, CEO, XinBridge, China (Chair) Dr. Blessed Okole PhD, CEO, Lifelab , South Africa Seminar title: " South African Biotechnology Industry An Emerging Bioeconomy" Dr. Zhenping Zhu MD, PhD Vice President, ImClone Seminar title: "Development of antibody cancer therapeutics at ImClone". Corie Lok Senior Editor, Nature Network Dr. James Zhu PhD Partner, Perkins Coie Dr. Stephen Lam PhD, MBA, Head, Biotechnology, HKSTP Seminar title: Hong Kong Science Park - it’s about the Business of Science
7:30 pm	Dinner Keynote presentation Dr Kai Wu, PhD, Novartis (Chair) Jim Sherblom, Managing General Partner, Seaflower Ventures Seminar title: "Venture Capital: locally funding for worldwide markets" Short Presentation by CEO or the international chiefs
8:30 pm	Smart pitch (Biotech who is who) Networking
9:00 pm	Close of day 1 & Transportation to Hotel

Day 2 Saturday: May 5, 2007

May 5, 2007	"The promise of the Biotechnology: Doing & investing R & D globally"
8:00 am	Networking with Dim Sum Breakfast
9:00 am	Welcome: Grace Wong PhD, CSO, ActoKine Therapeutics (5 min)
9:30 am to 11:30 am	Dr. Zhijian Lu PhD Associate Director, Wyeth (Chair) Dr. Arthur Coury, Ph.D. VP, Genzyme Seminar title: "Genzyme: A Highly Diversified Medical Products Company" (45 min) Dr. Makarand Jawadekar Director, Pfizer, CT Seminar Title: "The East is new West" (20 min) Dr. Amanda Caples Director-Biotech, State Government of Victoria, Australia Seminar title: "Biotech opportunities in Melbourne-Australia"(20 min)
12:00 am	Lunch presentation Dr. Dilip Limaye PhD, CEO, Indipharm, India Seminar title: Clinical Trials: The Next Frontier in US-India Cooperation (20 min) Li Hang Deputy Director General, SSL Sci and Tech Park, Dongguan, China Dr. Chris Song PhD, MBA, Applied Biosystems, China Title: "Pharmaceutical R&D and preclinical Services in China" (20 min)
2:00 pm to 4:00 pm	Lunch- presentation & panel discussion (Doing & investing R & D globally) Dr. Lorenz Ng MD, CEO, Global Ng Associates, Former VP, Eli Lilly Asia (Moderator) Dr. Zach Jonasson, PhD, Senior Principal, Seaflower Ventures Dr. Claude Ranoux, PhD, CEO, BioXcell, France Dr. Christoph Hüls PhD, CEO, Protagen AG, Germany "UNIarray: systematic discovery and verification of novel antibody signatures suitable as biomarkers" Dr. Richard Gill PhD, CEO, ProNAi Therapeutics, USA "Proprietary Nucleic Acid Based Interfering Technology (DNAi)" Lance Han MBA, CEO, Cyagen, Guangzhou, China Qiang Yu, PhD, CEO, Shanghai Ambrosia Pharmaceutical, China Dr Frank Lee CEO, Dragonfly, Shanghai, China Dr. David Irving PhD, CEO, Diabetes Vaccine Development Centre, Australia "DVDC - bridging the gap: type 1 diabetes immunotherapeutics" Dr. Choong-Chin Liew PhD, Chief Scientist, GeneNews, Toronto , Canada "Doing Biotech R&D Globally: Blood Transcriptome Mirrors Molecular Signature of Disease" Presentation from other international chiefs Drs. Steve Gullans, CEO, Rx-gen, David He, Abbott , Chuck Caprariello, Ranbaxy, India
4:00 pm	Networking
4:30 pm to 6:00 pm	Edward Brennan COO, Indipharm, India (Chair) Xhinan Xia, Wyeth Jianling Wang PhD, Novartis Institute Dr. Reinhard Ebner PhD, Avalon Pharmaceuticals (Chair) Kevin Cronin CEO, Techlawglobal, Beijing, China Title: "The Tao of the Deal: Lessons Learned from Pharma Projects in Asia" Iskandar Mizal Mahmood, CEO, Malaysian Biotechnology Corporation Kevin Zhou MBA, CEO, SSTK Biotech, Shenzhen, China Huo Li, PhD, Biogen-Idec & Patricia Turney, Director, R&D Strategic Operations, Amgen Dr. Stephen Ip, PhD, Sr. VP, TaiGen, Taiwan Title: "Biotech Research in Taiwan: Opportunities and Challenges"
6:30 pm	Banquet Dinner Keynote Presentation Carlos Genardini CEO, Hong Kong Science and Technology Parks Title: "Reality Check-Can Entrepreneurs Succeed in China's Life Science Business"
7:30pm	Short Presentation by CEO or the international chiefs Dr. Lindsay Woods, Proteome, Australia Jean-François Mouney, CEO, Genfit Corp, France
8:30 pm to 9:00 pm	Smart pitch (Biotech who is who) Concluding remark and Networking & Close of day 2
9:00 pm	Transportation to Hotel

Agendas & Photos for Past Linus Pauling Biotech Events:

11th Pauling Biotech Symposium - October 30, 2006, South San Francisco
Agenda & Photos

10th Pauling Biotech Symposium - Sept 2, 2006, HKSP, Hong Kong
Agenda

9th Pauling Biotech Symposium - April 7-9, 2006 Hyatt, Chicago
Agenda

8th Pauling Biotech Symposium - February 26, 2006, MIT Faculty Club, Cambridge
Agenda

7th Pauling Biotech Symposium - February 23-25, 2006, MIT Faculty Club, Cambridge
Agenda & Photos

6th Pauling Biotech Symposium - December 25, 2003, Boston
Agenda & Photos

5th Pauling Biotech Symposium - November 27, 2003, Boston
Agenda & Photos

4th Pauling Biotech Symposium - October 11, 2003, Boston
New Target Identification by Novel Technologies, Genomics and Bioinformatics
Agenda & Photos

3rd Pauling Biotech Symposium - September 28, 2003, boston
Cytokines and Angiogenesis: Academia vs. Industry for New drug discovery
Agenda & Photos

2nd Pauling Biotech Symposium - July 30, 2003, Boston
Genomics for New Target Identification: Biotech vs. Big Pharma
Agenda & Photos

1st Pauling Biotech Symposium - June 11, 2003, Boston
Cytokine Genomics and RNAi for New Target Validation
Agenda & Photos